Published in J Pharmacol Exp Ther on April 01, 2001
Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration. Mol Pharmacol (2006) 1.24
Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. Br J Pharmacol (2005) 1.16
Endocannabinoid signalling in reward and addiction. Nat Rev Neurosci (2015) 1.04
Cannabinoid-opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol (2009) 1.02
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system. PLoS One (2014) 0.80
The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther (1994) 2.55
mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res Mol Brain Res (1998) 1.08
The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol. Pharmacol Biochem Behav (1998) 1.04
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Pharmacol Biochem Behav (1998) 0.99
Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice. J Pharmacol Exp Ther (1994) 0.98
Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification. J Pharmacol Exp Ther (1999) 0.96
Involvement of calcium and L-type channels in nicotine-induced antinociception. J Pharmacol Exp Ther (1993) 0.90
The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord. J Pharmacol Exp Ther (1996) 0.88
Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception. Eur J Pharmacol (1999) 0.86
Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide. Brain Res (2000) 0.86
Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord. J Pharmacol Exp Ther (1997) 0.85
Antinociceptive activity of intrathecal ketorolac is blocked by the kappa-opioid receptor antagonist, nor-binaltorphimine. Eur J Pharmacol (1993) 0.85
Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice. Drug Alcohol Depend (1997) 0.85
Postpartum women in outpatient drug abuse treatment: correlates of retention/completion. J Psychoactive Drugs (1996) 0.85
Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. Agents Actions (1990) 0.84
In vivo pharmacological effects of dihydro-beta-erythroidine, a nicotinic antagonist, in mice. Psychopharmacology (Berl) (1995) 0.83
Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist. Psychopharmacology (Berl) (1995) 0.82
Nicotine-induced antinociception in mice: role of G-proteins and adenylate cyclase. Pharmacol Biochem Behav (1994) 0.82
Inhibition of protein phosphatases alters the expression of morphine tolerance in mice. Eur J Pharmacol (1998) 0.80
The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids. Eur J Pharmacol (2001) 0.79
Antisense oligodeoxynucleotides to the kappa-1 receptor block the antinociceptive effects of delta 9-THC in the spinal cord. Brain Res (1995) 0.79
Progress toward understanding the cannabinoid receptor and its second messenger systems. Adv Pharmacol (1994) 0.78
The mouse paw withdrawal assay: a method for determining the effect of calcitonin gene-related peptide on cutaneous heat nociceptive latency time. Life Sci (1993) 0.78
ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides. Eur J Pharmacol (1999) 0.78
Evaluation of cAMP involvement in cannabinoid-induced antinociception. Life Sci (1995) 0.78
Characterization and modulation of acute tolerance to nicotine in mice. J Pharmacol Exp Ther (1996) 0.78
A diminution of delta9-tetrahydrocannabinol modulation of dynorphin A-(1-17) in conjunction with tolerance development. Eur J Pharmacol (1999) 0.78
The effects of dynorphin A (1-13) and U50, 488H on free intracellular calcium in guinea pig cerebellar synaptosomes. Life Sci (1991) 0.78
The role of endogenous peptides in the action of opioid analgesics. Ann Emerg Med (1986) 0.77
Differential effects of divalent cations, cation chelators and an ionophore (A23187) on morphine and dibutyryl guanosine 3': 5'-cyclic monophosphate antinociception. J Pharmacol Exp Ther (1980) 0.76
Antisenses to opioid receptors attenuate ATP-gated K(+) channel opener-induced antinociception. Eur J Pharmacol (1999) 0.76
Alterations in L-type calcium channels in the brain and spinal cord of acutely treated and morphine-tolerant mice. Brain Res (1995) 0.75
A method for the determination of activated receptor phosphorylation state following in vivo drug treatment. Brain Res Brain Res Protoc (1999) 0.75
Comparison of [(3)H]Glyburide binding with opiate analgesia, tolerance, and dependence in ICR and Swiss-Webster mice. J Pharmacol Exp Ther (2000) 0.75
The role of endogenous opioids as mediators of the hypothermic effects of intrathecally administered calcium and calcitonin gene-related peptide in mice. J Pharmacol Exp Ther (1993) 0.75
Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice. J Pharmacol Exp Ther (1988) 0.75
A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate in mice. J Pharmacol Exp Ther (1986) 0.75
Modulation of free intracellular calcium and cAMP by morphine and cannabinoids, alone and in combination in mouse brain and spinal cord synaptosomes. Pharmacol Biochem Behav (1994) 0.75
Antinociceptive activity of salmon calcitonin injected intraventricularly in mice: modulation of morphine antinociception. J Pharmacol Exp Ther (1986) 0.75
The hypothermic and antinociceptive effects of intrathecal injection of CGRP (8-37) in mice. Life Sci (1994) 0.75
Blockade of the antinociceptive activity of centrally administered ketorolac by nor-binaltorphimine. Eur J Pharmacol (1995) 0.75
Antisense oligodeoxynucleotides to the kappa1 receptor enhance delta9-THC-induced antinociceptive tolerance. Pharmacol Biochem Behav (1998) 0.75
Antinociceptive and lethal effects of intraventricularly administered barium and strontium: antagonism by atropine sulfate or naloxone hydrochlorine. Life Sci (1983) 0.75